Anterior Lumbar Interbody Fusion for Treatment of Failed Back Surgery Syndrome: An Outcome Analysis….Neil Duggal, M.D., M.Sc., Ignacio Mendiondo, M.D., Heraldo R. Pares, M.D., Balraj S. Jhawar, M.D., Ph.D., Kaushik Das, M.D., Kathy J. Kenny, R.N., M.S., Curtis A. Dickman, M.D.

Neurosurgery ◽  
2004 ◽  
Vol 54 (2) ◽  
pp. A2-A2
Keyword(s):  
Interbody Fusion ◽  
Failed Back Surgery Syndrome ◽  
Anterior Lumbar Interbody Fusion ◽  
Outcome Analysis ◽  
Lumbar Interbody Fusion ◽  
Failed Back Surgery ◽  
Back Surgery

Anterior Lumbar Interbody Fusion for Treatment of Failed Back Surgery Syndrome: An Outcome Analysis

Neurosurgery ◽  
2004 ◽  
Vol 54 (3) ◽  
pp. 636-644 ◽  
Author(s):  
Neil Duggal ◽  
Ignacio Mendiondo ◽  
Heraldo R. Pares ◽  
Balraj S. Jhawar ◽  
Kaushik Das ◽  
...  
Keyword(s):  
Interbody Fusion ◽  
Perioperative Complications ◽  
Failed Back Surgery Syndrome ◽  
Anterior Lumbar Interbody Fusion ◽  
Leg Pain ◽  
Outcome Analysis ◽  
Lumbar Interbody Fusion ◽  
Disc Disease ◽  
Failed Back Surgery ◽  
Back Surgery

Abstract OBJECTIVE Anterior lumbar interbody fusion (ALIF) has gained popularity for the treatment of degenerative disease of the lumbar spine. In this report, we present our experience with the ALIF procedure for treatment of failed back surgery syndrome (FBSS) in a noncontrolled prospective cohort. METHODS In a 2-year period, we treated patients diagnosed with FBSS with ALIF. Clinical and radiological outcomes were recorded in a prospective, nonrandomized, longitudinal manner. Neurological, pain, and functional outcomes were measured preoperatively and 12 months after surgery. Operative data, perioperative complications, and radiological and clinical outcomes were recorded. RESULTS Thirty-three patients with a preoperative diagnosis of FBSS, with degenerative disc disease (n = 17), postsurgical spondylolisthesis (n = 13), or pseudarthrosis (n = 3), underwent ALIF. Back pain, leg pain, and functional status improved significantly, by 76% (P < 0.01), 80% (P < 0.01), and 67% (P < 0.01), respectively. CONCLUSION On the basis of our results, we found ALIF to be a safe and effective procedure for the treatment of FBSS for selected patients.

Long-term quality of life and work status after high-dose spinal cord stimulation in patients with failed back surgery syndrome: a secondary analysis of real-world data

2020 ◽  
pp. 1-9
Author(s):  
Lisa Goudman ◽  
Ann De Smedt ◽  
Koen Putman ◽  
Maarten Moens ◽  
_ _
Keyword(s):  
Normal Population ◽  
Failed Back Surgery Syndrome ◽  
Work Status ◽  
High Dose ◽  
Difference Scores ◽  
Failed Back Surgery ◽  
Back Surgery ◽  
Vas Scores ◽  
Utility Scores

OBJECTIVEIn recent years, the use of high-dose spinal cord stimulation (HD-SCS) as a treatment option for patients with failed back surgery syndrome (FBSS) has drastically increased. However, to the authors’ knowledge a thorough evaluation of health-related quality of life (HRQOL) and work status in these patients has not yet been performed. Moreover, it is unclear whether patients who are treated with HD-SCS can regain the same levels of HRQOL as the general population. Therefore, the aims of this study were to compare the HRQOL of patients who receive HD-SCS to HRQOL values in an age- and sex-adjusted population without FBSS and to evaluate work status in patients who are receiving HD-SCS.METHODSHRQOL, measured with the 3-level EQ-5D (EQ-5D-3L), and work status were evaluated in 185 FBSS patients at baseline (i.e., before SCS) and at 1, 3, and 12 months of treatment with HD-SCS. Difference scores in utility values between patients and an age- and sex-adjusted normal population were calculated. One-sample Wilcoxon tests were used to assess the EQ-5D-3L difference scores. Mixed models were used to evaluate the evolution over time in EQ-5D-3L utility scores and EQ-5D visual analog scale (VAS) scores in patients and matched controls. Quality-adjusted life-years (QALYs) were calculated using the area under the curve method.RESULTSAn overall significant increase in EQ-5D-3L utility scores and EQ-5D VAS scores was found over time in the patient group. Wilcoxon tests indicated that the difference scores in utility values between patients and the normal population were significantly different from zero at all time points. The median incremental QALY after 12 months of HD-SCS was 0.228 (Q1–Q3: 0.005–0.487) in comparison to continued conservative treatment. At 12 months, 13.75% of patients resumed work.CONCLUSIONSHD-SCS may lead to significantly increased HRQOL at 12 months in patients with FBSS. Despite the increase, reaching the HRQOL level of matched controls was not achieved. Only a limited number of patients were able to return to work. This finding indicates that specialized programs to enhance return to work may be beneficial for patients undergoing SCS.

Sign in / Sign up

Export Citation Format

Share Document